ArticleCureus2024
Pulmonary Arterial Hypertension in a Patient With a Lung Mass: Any Link?
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 52-year-old female patient with a history of atrial septal defect repair presented with progressive dyspnea and echocardiographic findings suggestive of pulmonary hypertension (PH). Incidentally, a lung mass was discovered on computed tomography (CT). Initial evaluation revealed World Health Organization functional class III symptoms and significant weight loss. Diagnostic workup included echocardiography, pulmonary function tests, CT chest, computed tomography pulmonary angiography, right heart catheterization, and positron emission tomography. Supraclavicular lymph node biopsy confirmed adenocarcinoma of pulmonary origin with positive epidermal growth factor receptor (EGFR) mutation. Right heart catheterization demonstrated vasoreactive pre-capillary PAH. The patient was initiated on nifedipine, which was gradually titrated. Subsequent ventilation-perfusion scan revealed chronic thromboembolic pulmonary hypertension (CTEPH), leading to anticoagulation therapy. We are reporting this case of PAH which presented with features of Group 4 PH and had a sarcoid-like reaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.